Delaying colonoscopy after positive stool-based screening test increases CRC rates, study finds

Patients must confirm a positive stool-based colorectal cancer screening test with a colonoscopy, and delaying that follow-up colonoscopy has led to increased CRC rates, according to a study published in Gastroenterology Feb. 2.

Advertisement

Researchers performed a retrospective cohort study on 204,733 veterans with abnormal fecal occult blood tests or fecal immunochemical tests.

All patients received a follow-up colonoscopy. Patients who waited 13 to 15 months, 16 to 18 months, 19 to 21 months or 22 to 24 months for a follow-up colonoscopy had an increased risk of CRC compared to patients who received a colonoscopy at one to three months.

Mortality risk was highest in groups who received a colonoscopy after 19 months or more, and patients who waited 16 months or more faced increased odds for late-stage CRC.

Researchers concluded, “Increased time to colonoscopy is associated with higher risk of CRC incidence, death, and late stage CRC after abnormal FIT/FOBT. Interventions to improve CRC outcomes should emphasize diagnostic follow-up within 1 year of an abnormal FIT/FOBT result.”

More articles on surgery centers:
Intermountain Healthcare campus in Utah to include ASC
Alabama hospital seeks approval to turn outpatient department into ASC in $4M project
Biden exec order reopens ACA insurance marketplaces: What ASCs need to know

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.